Crossmark

Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

Crossref DOI link: https://doi.org/10.1016/j.medcle.2015.09.005

Published Print: 2016-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mar, Javier

Mar-Barrutia, Lorea

Gimeno-Ballester, Vicente

San Miguel, Ramón
License Information

Text and Data Mining valid from 2016-01-01
More Information

This article is maintained by: Elsevier

Article Title: Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2015.09.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2015.09.019

Content Type: simple-article

Copyright: © 2015 Elsevier España, S.L.U. All rights reserved.